Sage Journals: Discover world-class research

Free access

Review article

First published 2016-5

Clinical experience with infliximab biosimilar Remsima (CT-P13) in inflammatory bowel disease patients

Jørgen Jahnsen

Therapeutic Advances in Gastroenterology

Open access

Case report

First published 2022

A case report of drug-induced liver injury due to the infliximab biosimilar CT-P13 on switching from original infliximab in a patient with Crohn’s disease

Shin Kashima, Koji Sawada, Kentaro Moriichi [...]

Therapeutic Advances in Drug Safety

Open access

Research article

First published 2018

Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease

Viktoria Bergqvist, Mohammad Kadivar, Daniel Molin [...]

Therapeutic Advances in Gastroenterology

Free access

Review article

First published 2016-9

Experience with biosimilar infliximab (CT-P13) in paediatric patients with inflammatory bowel diseases

Joanna Sieczkowska, Dorota Jarzębicka, Monika Meglicka [...]

Therapeutic Advances in Gastroenterology

Open access

Review article

First published 2019

Switching from infliximab to biosimilar in inflammatory bowel disease: overview of the literature and perspective

Ágnes Milassin, Anna Fábián, Tamás Molnár

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2019

Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data

María Fernanda Guerra Veloz, María Belvis Jiménez, Teresa Valdes Delgado [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2017-9

Therapeutic drug monitoring of CT-P13: a comparison of four different immunoassays

Joana Afonso, Helena Tavares de Sousa, Isadora Rosa [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2025

Safety outcomes in 2132 Danish patients with inflammatory arthritis treated with biosimilar infliximab (GP1111) in routine care

Hafsah Nabi, Kasper Yde Jensen, Rasmus Westermann [...]

Therapeutic Advances in Musculoskeletal Disease

Search results